Avaleht › Geograafiline atroofia › Washington
Geograafiline atroofia kliinilised uuringud osariigis Washington
6 uuringut haiguse Geograafiline atroofia jaoks otsivad osalejaid osariigis Washington.
Linnad osariigis Washington
Ametlik uuringutekst (inglise keeles)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Spokane Eye Clinical Research, Spokane
VärbamineFaas 2/3
Vanused 60 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT06635148A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Spokane Eye Clinic, Spokane
VärbamineFaas 1/2
Vanused 55 ja vanemad · Kõik sood · Uuendatud 23. sept 2026 · NCT07029945A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Spokane Eye Clinical Research, Spokane
VärbamineFaas 3
Vanused 50–85 · Kõik sood · Uuendatud 18. sept 2026 · NCT06541704A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
- Spokane Eye Clinical Research;Spokane Eye Surgery Center, Spokane
VärbamineFaas 2
Vanused 50 ja vanemad · Kõik sood · Uuendatud 15. sept 2026 · NCT05626114Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Pacific Northwest Retina, Bellevue
- Pacific Northwest Retina, PLLC, Silverdale
VärbamineFaas 2
Vanused 55 ja vanemad · Kõik sood · Uuendatud 10. sept 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Spokane Eye Clinical Research, Spokane
VärbamineFaas 1
Vanused 50 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT03178149Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.